ArticlePharmaceuticals (Basel, Switzerland)2025

The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis.

Stefano Kette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.